MedTrace Logo

SUbstition of PERioperative Albumin Deficiency Disorders

NCT03167645 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2021-04-23

No results posted yet for this study

Summary

Aim of this study is to reduce postoperative complications (assessed by POMS-Score and graded by Clavien-Dindo-Score) by substitution of perioperative hypoalbuminaemia in high-risk patients or patients undergoing high risk surgery.

Conditions

Interventions

DRUG

Human albumin

Substitution according to pre-specified dosage

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Manfred Blobner, MD · Klinikum rechts der Isar, Technical University Munich, Dept. of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2019-12-21
Completion
2021-04-21

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167645 on ClinicalTrials.gov